The Impact of a Home Delivered Meal Service in Cancer Patients During Chemotherapy
8 oktober 2020 bijgewerkt door: Radboud University Medical Center
The Impact of FoodforCare at Home on Quality of Life of Cancer Patients Undergoing Chemotherapy.
Cancer patients receiving treatment such as chemotherapy experience a variety of symptoms that interfere with their appetite and their ability to eat and enjoy meals.
Therefore, adapting meals in a way that responds to these symptoms might be a good strategy to improve patient satisfaction, nutritional status and hence, quality of life.
In this vein, the investigators hypothesize that meals from FoodforCare at Home will contribute to the quality of life of cancer patients undergoing chemotherapy when compared to usual care.
Studie Overzicht
Gedetailleerde beschrijving
Cancer patients receiving treatment such as chemotherapy experience a variety of symptoms that interfere with their appetite and their ability to eat and enjoy meals.
Several studies suggest that nutritional intake increases when the patient is satisfied about the quality of the meals.
Therefore, adapting meals in a way that responds to these symptoms might be a good strategy to improve patient satisfaction, nutritional status and hence, quality of life.
In this vein, the investigators hypothesize that meals from FoodforCare at Home will contribute to the quality of life of cancer patients undergoing chemotherapy when compared to usual care.
Also, the investigators expect that this strategy will have a positive effect on patient satisfaction, other nutrition-related issues, including nausea and vomiting, on nutritional intake per se and hence, on the nutritional status.
Additional benefits might include reduced use of medication, especially anti-emetics.
Studietype
Ingrijpend
Inschrijving (Werkelijk)
148
Fase
- Niet toepasbaar
Contacten en locaties
In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.
Studie Locaties
-
-
Gelderland
-
Nijmegen, Gelderland, Nederland, 6525 GA
- Radboudumc
-
-
Deelname Criteria
Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
18 jaar en ouder (Volwassen, Oudere volwassene)
Accepteert gezonde vrijwilligers
Nee
Geslachten die in aanmerking komen voor studie
Allemaal
Beschrijving
Inclusion Criteria:
- age 18 years or older
- diagnosed with cancer
- receiving chemotherapy according to a minimum schedule of every 2 weeks
- living within a 40 km radius around the Radboud University Nijmegen Medical Centre
- written informed consent
Exclusion Criteria:
- renal insufficiency (MDRD-GFR (glomerular filtration rate) < 60ml/min and/or proteinuria)*
- dementia or any other condition which makes it impossible to fill out questionnaires correctly
- unable to understand or speak Dutch
- depending on artificial nutrition in the form of Oral Nutritional Supplements, tube feeding or total parenteral nutrition
swallowing or passage problems
- proteinuria is defined in case of a protein creatinine ratio > 0.5g/10mmol or an albuminuria > 300mg/day. This is checked by default before the start of chemotherapy by the treating physician to decide whether or not the patient is eligible for receiving chemotherapy.
Studie plan
Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ondersteunende zorg
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: FoodforCare group
The intervention group will receive meals from FoodforCare at Home.
The FoodforCare at Home concept consists of five to six small protein and energy enriched meals that will be delivered twice a week.
After an individual intake, the composition of the dishes will be tailored to the needs of the patient in terms of composition, diet, taste, flavor and portion size.
Besides the meals, patients in the intervention group will also receive an information leaflet about the importance of protein during treatment and how to reach their protein requirements.
|
Five small protein rich meals that will be delivered twice a week for 3 weeks.
|
|
Geen tussenkomst: Usual care group
The control group will continue their usual diet for 3 weeks and have no restrictions to their diet.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Quality of life and overall health status
Tijdsspanne: 3.5 months
|
EORTC-Quality of Life-C30 questionnaire filled in before chemotherapy, two times during chemotherapy and after chemotherapy.
This questionnaire consists of 30 questions and a total score ranging from 0-100 is calculated based on these questions.
The higher the score, the higher the quality of life of the patient.
|
3.5 months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Nutritional intake
Tijdsspanne: 3.5 months
|
2-day food diary filled in before chemotherapy, two times during chemotherapy and after chemotherapy.
|
3.5 months
|
|
Muscle strength
Tijdsspanne: 3.5 months
|
Hand grip strength (kg) performed before chemotherapy, two times during chemotherapy and once after chemotherapy.
|
3.5 months
|
|
Nutritional status
Tijdsspanne: 3.5 months
|
Patient Generated Subjective Global Assessment (PG-SGA) performed before chemotherapy, two times during chemotherapy and once after chemotherapy.
|
3.5 months
|
|
Functional score
Tijdsspanne: 3.5 months
|
Karnofsky scale performed before chemotherapy, two times during chemotherapy and once after chemotherapy.
This status is based on 11 levels and ranges from 0, indicating death, to 100, indicating no complaints or evidence of disease.
|
3.5 months
|
|
Quality of life caregiver
Tijdsspanne: 3.5 months
|
Caregiver Reaction Assessment (CRA) filled in before chemotherapy, two times during chemotherapy and once after chemotherapy.
This questionnaire consist of 24 items in five subscales.
All items are statements with a 5-point Likert scale (completely disagree-completely agree).
All subscale scores are the average of the item scores, ranging from 1 to 5.
There is no total score.
|
3.5 months
|
|
Medication use
Tijdsspanne: 3 weeks
|
Diary filled in during 3 weeks between 2 cycles of chemotherapy
|
3 weeks
|
|
Symptoms
Tijdsspanne: 3 weeks
|
Symptom diary filled in during 3 weeks between 2 cycles of chemotherapy
|
3 weeks
|
|
Patient satisfaction
Tijdsspanne: 1 day
|
Questionnaire filled in after 3 weeks of receiving meals.
This is a self-developed questionnaire which does not have a total score.
Each question will be analyzed separately.
Questions consist of grading from 0-10 (the higher, the better the outcome) or with a 5-point Likert scale (completely disagree-completely agree).
|
1 day
|
|
Functional status
Tijdsspanne: 3.5 months
|
Short Physical Performance Battery (SPPB) performed before chemotherapy, two times during chemotherapy and once after chemotherapy.
|
3.5 months
|
Medewerkers en onderzoekers
Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.
Onderzoekers
- Studie stoel: Manon van den Berg, PhD, Radboud University Medical Center
Publicaties en nuttige links
De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.
Algemene publicaties
- Coa KI, Epstein JB, Ettinger D, Jatoi A, McManus K, Platek ME, Price W, Stewart M, Teknos TN, Moskowitz B. The impact of cancer treatment on the diets and food preferences of patients receiving outpatient treatment. Nutr Cancer. 2015;67(2):339-53. doi: 10.1080/01635581.2015.990577. Epub 2015 Feb 9.
- Teunissen SC, Wesker W, Kruitwagen C, de Haes HC, Voest EE, de Graeff A. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage. 2007 Jul;34(1):94-104. doi: 10.1016/j.jpainsymman.2006.10.015. Epub 2007 May 23.
- Campbell AD, Godfryd A, Buys DR, Locher JL. Does Participation in Home-Delivered Meals Programs Improve Outcomes for Older Adults? Results of a Systematic Review. J Nutr Gerontol Geriatr. 2015;34(2):124-67. doi: 10.1080/21551197.2015.1038463.
- Dashti HS, Mogensen KM. Recommending Small, Frequent Meals in the Clinical Care of Adults: A Review of the Evidence and Important Considerations. Nutr Clin Pract. 2017 Jun;32(3):365-377. doi: 10.1177/0884533616662995. Epub 2016 Sep 1.
- Marin Caro MM, Laviano A, Pichard C. Nutritional intervention and quality of life in adult oncology patients. Clin Nutr. 2007 Jun;26(3):289-301. doi: 10.1016/j.clnu.2007.01.005. Epub 2007 Mar 21.
- Leedo E, Gade J, Granov S, Mellemgaard A, Klausen TW, Rask K, Astrup A. The Effect of a Home Delivery Meal Service of Energy- and Protein-Rich Meals on Quality of Life in Malnourished Outpatients Suffering from Lung Cancer: A Randomized Controlled Trial. Nutr Cancer. 2017 Apr;69(3):444-453. doi: 10.1080/01635581.2017.1283421. Epub 2017 Feb 17.
- IJmker-Hemink V, Lize N, Beijer S, Raijmakers N, Wanten G, van den Berg M. Lessons learned from a randomized controlled trial on a home delivered meal service in advanced cancer patients undergoing chemotherapy: a pilot study. BMC Nutr. 2021 Feb 16;7(1):4. doi: 10.1186/s40795-021-00407-5.
Studie record data
Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.
Bestudeer belangrijke data
Studie start (Werkelijk)
17 november 2017
Primaire voltooiing (Werkelijk)
22 mei 2020
Studie voltooiing (Werkelijk)
22 mei 2020
Studieregistratiedata
Eerst ingediend
23 november 2017
Eerst ingediend dat voldeed aan de QC-criteria
18 december 2017
Eerst geplaatst (Werkelijk)
22 december 2017
Updates van studierecords
Laatste update geplaatst (Werkelijk)
9 oktober 2020
Laatste update ingediend die voldeed aan QC-criteria
8 oktober 2020
Laatst geverifieerd
1 april 2019
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 2016-3044
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Nee
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Nee
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Nee
product vervaardigd in en geëxporteerd uit de V.S.
Nee
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .